IL2 and myeloid sarcoma: We enrolled 12 MS Relapsing Remitting patients and primary NK cells from these patients were purified, expanded by IL-2 and IL-15 stimulation [47] and sorted into KIR2DL2 positive and KIR2DL2 negative NK cell subsets using anti-KIR2DL2 coated beads.